Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Inventory (2016 - 2025)

Fortress Biotech (FBIO) has 10 years of Change in Inventory data on record, last reported at -$1.0 million in Q3 2025.

  • For Q3 2025, Change in Inventory fell 149.21% year-over-year to -$1.0 million; the TTM value through Sep 2025 reached $30000.0, down 96.07%, while the annual FY2024 figure was $4.2 million, 206.88% up from the prior year.
  • Change in Inventory reached -$1.0 million in Q3 2025 per FBIO's latest filing, down from $356000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $12.0 million in Q2 2021 and bottomed at -$2.7 million in Q3 2021.
  • Average Change in Inventory over 5 years is $230157.9, with a median of -$823000.0 recorded in 2022.
  • The widest YoY moves for Change in Inventory: up 2632.73% in 2021, down 1620.38% in 2021.
  • A 5-year view of Change in Inventory shows it stood at -$1.8 million in 2021, then soared by 38.87% to -$1.1 million in 2022, then rose by 23.62% to -$818000.0 in 2023, then soared by 423.11% to $2.6 million in 2024, then plummeted by 139.12% to -$1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$1.0 million in Q3 2025, $356000.0 in Q2 2025, and -$1.9 million in Q1 2025.